- McLaughlin, P., Grillo-Lopez, A. and Link, B. (1998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a 4-dose treatment regimen". Journal of Clinical Oncology 16, 2825-2833.
- Vose, J.M. (1999) "Antibody-targeted therapy for low-grade lymphoma". Seminars in Hematalogy 36(4 Suppl. 6), 15-20.
- Press, O.W. (2000) Innovative New Therapies for Non-Hodgkin's Lymphoma: Monoclonal Antibodies and Immunoconjugates (ASCO Educational Book), pp 328-337.
- Thomas, A. (2000) "Rituximab anti-CD20 monoclonal antibody therapy in non-hodgkin's lymphoma: safety and efficacy of retreatment". Journal of Clinical Oncalogy 18, 3135-3143
Rituximab in Lymphoma with Life Threatening Haemolysis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.